Cesca Therapeutics Inc (NASDAQ:KOOL) announced today it has received Notice of Allowance for U.S.
Shares of Cesca Therapeutics Inc (NASDAQ:KOOL) jumped nearly 18% higher today, after the U.S.
In a research note released today, H.C.
In a research report released today, Maxim Group analyst Jason Kolbert maintained a Buy rating on Cesca Therapeutics (NASDAQ: KOOL) with a $7 price …
In a research note published yesterday, Maxim Group analyst Jason Kolbert reaffirmed a Buy rating on Cesca Therapeutics (KOOL) with a $7 price target, on …
In a research report released yesterday, H.C.
Maxim maintains a Buy rating and $7.00 price target on Cesca Therapeutics Inc.
In a research note released earlier today, H.C.
In a research noted released today, H.C.
